{
  "hash": "33caf7ded023e7f9c57d5f4852a8b1ba",
  "result": {
    "engine": "knitr",
    "markdown": "# National Drug Codes {#sec-ndcapi}\n\n\n\n## Links\n\n   * [`openFDA` NDC API: Home](https://open.fda.gov/apis/drug/ndc/)\n   * [`openFDA` NDC API: How to use the API](https://open.fda.gov/apis/drug/ndc/how-to-use-the-endpoint/)\n   * [FDA: Drug Approvals and Databases](https://www.fda.gov/drugs/development-approval-process-drugs/drug-approvals-and-databases)\n   * [NIH: `RxNorm`](https://lhncbc.nlm.nih.gov/RxNav/APIs/api-RxNorm.getNDCProperties.html)\n\n## Catalog\n\n::: {.cell}\n\n```{.r .cell-code}\n\"https://api.fda.gov/drug/ndc.json\" |> \n  request() |> \n  req_perform() |> \n  resp_body_string() |> \n  jsonify::pretty_json()\n```\n\n::: {.cell-output .cell-output-stdout}\n\n```\n{\n    \"meta\": {\n        \"disclaimer\": \"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.\",\n        \"terms\": \"https://open.fda.gov/terms/\",\n        \"license\": \"https://open.fda.gov/license/\",\n        \"last_updated\": \"2025-02-25\",\n        \"results\": {\n            \"skip\": 0,\n            \"limit\": 1,\n            \"total\": 129819\n        }\n    },\n    \"results\": [\n        {\n            \"product_ndc\": \"77333-831\",\n            \"generic_name\": \"Sodium Bicarbonate\",\n            \"labeler_name\": \"Gendose Pharmaceuticals, LLC\",\n            \"brand_name\": \"Sodium Bicarbonate 10 GR. (650 MG)\",\n            \"brand_name_suffix\": \"10 GR. (650 MG)\",\n            \"active_ingredients\": [\n                {\n                    \"name\": \"SODIUM BICARBONATE\",\n                    \"strength\": \"650 mg/1\"\n                }\n            ],\n            \"finished\": true,\n            \"packaging\": [\n                {\n                    \"package_ndc\": \"77333-831-10\",\n                    \"description\": \"100 BLISTER PACK in 1 BOX (77333-831-10)  / 1 TABLET in 1 BLISTER PACK (77333-831-25)\",\n                    \"marketing_start_date\": \"20200515\",\n                    \"sample\": false\n                }\n            ],\n            \"listing_expiration_date\": \"20251231\",\n            \"openfda\": {\n                \"manufacturer_name\": [\n                    \"Gendose Pharmaceuticals, LLC\"\n                ],\n                \"rxcui\": [\n                    \"198861\"\n                ],\n                \"spl_set_id\": [\n                    \"ee90d829-9f1f-52ae-e053-2995a90a29ce\"\n                ],\n                \"is_original_packager\": [\n                    true\n                ],\n                \"unii\": [\n                    \"8MDF5V39QO\"\n                ]\n            },\n            \"marketing_category\": \"OTC MONOGRAPH DRUG\",\n            \"dosage_form\": \"TABLET\",\n            \"spl_id\": \"0e765edc-2647-533a-e063-6394a90a7c53\",\n            \"product_type\": \"HUMAN OTC DRUG\",\n            \"route\": [\n                \"ORAL\"\n            ],\n            \"marketing_start_date\": \"20200515\",\n            \"product_id\": \"77333-831_0e765edc-2647-533a-e063-6394a90a7c53\",\n            \"application_number\": \"M001\",\n            \"brand_name_base\": \"Sodium Bicarbonate\",\n            \"pharm_class\": [\n                \"Increased Large Intestinal Motility [PE]\",\n                \"Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]\",\n                \"Osmotic Activity [MoA]\",\n                \"Osmotic Laxative [EPC]\"\n            ]\n        }\n    ]\n}\n```\n\n\n:::\n:::\n\n",
    "supporting": [],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {},
    "engineDependencies": {},
    "preserve": {},
    "postProcess": true
  }
}